Kokonozaki et al. detected relations between FLT3L serum levels and those of multiple other MM proliferation markers (B-cell activating factor, c-reactive protein, lactate dehydrogenase (LDH), interleukin–6, and bone marrow ki-67 proliferative index) as well as known soluble angiogenic factors, such as vascular endothelial growth factor, tumor necrosis factor-α, endoglin, and hematopoietic growth factor [14,15]. This evidence concerns the gene FLT3LG and Miyoshi myopathy.